BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 11057674)

  • 1. Structure of a serpin-protease complex shows inhibition by deformation.
    Huntington JA; Read RJ; Carrell RW
    Nature; 2000 Oct; 407(6806):923-6. PubMed ID: 11057674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viscous drag as the source of active site perturbation during protease translocation: insights into how inhibitory processes are controlled by serpin metastability.
    Shin JS; Yu MH
    J Mol Biol; 2006 Jun; 359(2):378-89. PubMed ID: 16626735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
    Whisstock J; Lesk AM; Carrell R
    Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the local conformational change of alpha1-antitrypsin.
    Baek JH; Im H; Kang UB; Seong KM; Lee C; Kim J; Yu MH
    Protein Sci; 2007 Sep; 16(9):1842-50. PubMed ID: 17660256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa alpha 1-proteinase inhibitor Pittsburgh-trypsin covalent complex.
    Peterson FC; Gettins PG
    Biochemistry; 2001 May; 40(21):6284-92. PubMed ID: 11371190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational changes in serpins: I. The native and cleaved conformations of alpha(1)-antitrypsin.
    Whisstock JC; Skinner R; Carrell RW; Lesk AM
    J Mol Biol; 2000 Jan; 295(3):651-65. PubMed ID: 10623554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering thermostability in serine protease inhibitors.
    Im H; Ryu MJ; Yu MH
    Protein Eng Des Sel; 2004 Apr; 17(4):325-31. PubMed ID: 15126675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of conformational change in serpin structure and function.
    Gettins P; Patston PA; Schapira M
    Bioessays; 1993 Jul; 15(7):461-7. PubMed ID: 8379949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
    Finotti P; de Laureto PP
    Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational distributions of protease-serpin complexes: a partially translocated complex.
    Liu L; Mushero N; Hedstrom L; Gershenson A
    Biochemistry; 2006 Sep; 45(36):10865-72. PubMed ID: 16953572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neuroserpin: structure and time-dependent inhibition.
    Ricagno S; Caccia S; Sorrentino G; Antonini G; Bolognesi M
    J Mol Biol; 2009 Apr; 388(1):109-21. PubMed ID: 19265707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic intermediates en route to the final serpin-protease complex: studies of complexes of α1-protease inhibitor with trypsin.
    Maddur AA; Swanson R; Izaguirre G; Gettins PG; Olson ST
    J Biol Chem; 2013 Nov; 288(44):32020-35. PubMed ID: 24047901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimers initiate and propagate serine protease inhibitor polymerisation.
    Zhou A; Carrell RW
    J Mol Biol; 2008 Jan; 375(1):36-42. PubMed ID: 18005992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended intermolecular interactions in a serine protease-canonical inhibitor complex account for strong and highly specific inhibition.
    Fodor K; Harmat V; Hetényi C; Kardos J; Antal J; Perczel A; Patthy A; Katona G; Gráf L
    J Mol Biol; 2005 Jul; 350(1):156-69. PubMed ID: 15922357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 2.1 A resolution structure of an uncleaved alpha(1)-antitrypsin shows variability of the reactive center and other loops.
    Kim S; Woo J; Seo EJ; Yu M; Ryu S
    J Mol Biol; 2001 Feb; 306(1):109-19. PubMed ID: 11178897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic mechanism of protease inhibition by alpha1-antitrypsin.
    Kang UB; Baek JH; Ryu SH; Kim J; Yu MH; Lee C
    Biochem Biophys Res Commun; 2004 Oct; 323(2):409-15. PubMed ID: 15369767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxyanion-mediated inhibition of serine proteases.
    Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
    Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.
    Katz BA; Luong C
    J Mol Biol; 1999 Sep; 292(3):669-84. PubMed ID: 10497030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of a Michaelis serpin-protease complex.
    Ye S; Cech AL; Belmares R; Bergstrom RC; Tong Y; Corey DR; Kanost MR; Goldsmith EJ
    Nat Struct Biol; 2001 Nov; 8(11):979-83. PubMed ID: 11685246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.